These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 10397613)

  • 41. In vivo determination of the skin atrophy potential of the super-high-potency topical corticosteroid fluocinonide 0.1% cream compared with clobetasol propionate 0.05% cream and foam, and a vehicle.
    Gans EH; Sadiq I; Stoudemayer T; Stoudemayer M; Kligman AM
    J Drugs Dermatol; 2008 Jan; 7(1):28-32. PubMed ID: 18246695
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of polyoxypropylene 15 stearyl ether and propylene glycol on percutaneous penetration rate of diflorasone diacetate.
    Turi JS; Danielson D; Woltersom JW
    J Pharm Sci; 1979 Mar; 68(3):275-80. PubMed ID: 423113
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Use of a molecular form technique for the penetration of supersaturated solutions of salicylic acid across silicone membranes and human skin in vitro.
    Leveque N; Raghavan SL; Lane ME; Hadgraft J
    Int J Pharm; 2006 Aug; 318(1-2):49-54. PubMed ID: 16650701
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of chemical interactions in pentachlorophenol mixtures on skin and membrane transport.
    Baynes RE; Brooks JD; Mumtaz M; Riviere JE
    Toxicol Sci; 2002 Oct; 69(2):295-305. PubMed ID: 12377978
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Microemulsions as transdermal drug delivery vehicles.
    Kogan A; Garti N
    Adv Colloid Interface Sci; 2006 Nov; 123-126():369-85. PubMed ID: 16843424
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vivo human skin penetration of (-)-epigallocatechin-3-gallate from topical formulations.
    Scalia S; Trotta V; Bianchi A
    Acta Pharm; 2014 Jun; 64(2):257-65. PubMed ID: 24914725
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Maximum transepidermal flux for similar size phenolic compounds is enhanced by solvent uptake into the skin.
    Zhang Q; Li P; Roberts MS
    J Control Release; 2011 Aug; 154(1):50-7. PubMed ID: 21549777
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Systemic enhancement of papaverine transdermal gel for erectile dysfunction.
    Wen MM; El-Kamel AH; Khalil SA
    Drug Dev Ind Pharm; 2012 Aug; 38(8):912-22. PubMed ID: 22080854
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Alteration of skin hydration and its barrier function by vehicle and permeation enhancers: a study using TGA, FTIR, TEWL and drug permeation as markers.
    Shah DK; Khandavilli S; Panchagnula R
    Methods Find Exp Clin Pharmacol; 2008 Sep; 30(7):499-512. PubMed ID: 18985178
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reversible effects of permeation enhancers on human skin.
    Kang L; Poh AL; Fan SK; Ho PC; Chan YW; Chan SY
    Eur J Pharm Biopharm; 2007 Aug; 67(1):149-55. PubMed ID: 17270406
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transdermal delivery of ketorolac tromethamine: permeation enhancement, device design, and pharmacokinetics in healthy humans.
    Roy SD; Manoukian E
    J Pharm Sci; 1995 Oct; 84(10):1190-6. PubMed ID: 8801333
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bioequivalence Methodologies for Topical Drug Products: In Vitro and Ex Vivo Studies with a Corticosteroid and an Anti-Fungal Drug.
    Leal LB; Cordery SF; Delgado-Charro MB; Bunge AL; Guy RH
    Pharm Res; 2017 Apr; 34(4):730-737. PubMed ID: 28097506
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Assessing topical bioavailability and bioequivalence: a comparison of the in vitro permeation test and the vasoconstrictor assay.
    Lehman PA; Franz TJ
    Pharm Res; 2014 Dec; 31(12):3529-37. PubMed ID: 25005736
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Skin penetration of nonsteroidal antiinflammatory drugs out of a lipophilic vehicle: influence of the viable epidermis.
    Wenkers BP; Lippold BC
    J Pharm Sci; 1999 Dec; 88(12):1326-31. PubMed ID: 10585230
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Optimization of bioavailability of topical steroids: non-occluded penetration enhancers under thermodynamic control.
    Bennett SL; Barry BW; Woodford R
    J Pharm Pharmacol; 1985 May; 37(5):298-304. PubMed ID: 2862236
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative in vitro characterization of moxidectin and doramectin percutaneous absorption through bovine skin.
    Sallovitz JM; Nejamkin P; Lifschitz AL; Virkel GL; Imperiale FA; Lanusse CE
    J Vet Pharmacol Ther; 2012 Apr; 35(2):184-92. PubMed ID: 21521238
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Assessing vehicle effects on skin absorption using artificial membrane assays.
    Karadzovska D; Riviere JE
    Eur J Pharm Sci; 2013 Dec; 50(5):569-76. PubMed ID: 23474357
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A novel foam vehicle for delivery of topical corticosteroids.
    Huang X; Tanojo H; Lenn J; Deng CH; Krochmal L
    J Am Acad Dermatol; 2005 Jul; 53(1 Suppl 1):S26-38. PubMed ID: 15968261
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Combined effects of iontophoretic and chemical enhancement on drug delivery. II. Transport across human and murine skin.
    Nolan LM; Corish J; Corrigan OI; Fitzpatrick D
    Int J Pharm; 2007 Aug; 341(1-2):114-24. PubMed ID: 17502130
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Studying the effectiveness of penetration enhancers to deliver retinol through the stratum cornum by in vivo confocal Raman spectroscopy.
    Mélot M; Pudney PD; Williamson AM; Caspers PJ; Van Der Pol A; Puppels GJ
    J Control Release; 2009 Aug; 138(1):32-9. PubMed ID: 19401210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.